Endocyte, Inc. (a Novartis company)

Endocyte, Inc., a Novartis company, specializes in developing targeted therapies to improve and extend patients' lives. Leveraging Novartis's global platform, Endocyte focuses on innovative treatments primarily in oncology and other serious diseases, aiming to transform breakthrough science into transformative medicines.